Study | Species | Sex | Weight (g) | Age | N (T/no-T) | Model (establish; modeling standard) | Treatment group (administration;dose; course of treatment) | Outcome index |
---|---|---|---|---|---|---|---|---|
Chen [23] | Rat | Female | NA | 略 NA | 8/8 | Ovariectomy | Two weeks after OVX procedures; intragastric administration of 0.2 μM RES once;about 10 weeks | Bmd |
Jing Feng [25] | Rat | Female | 280–350 | 3 3 months | 8/8(low-dose)/8(middle)/8(high) | Ovariectomy | Orally administrated at the dosage of 5, 25and 45 mg/kg/d, respectively, 7 days after operation for 8 weeks | Bmd,BV/TV, Tb.Th,Tb.N, Tb.Sp, alp,oc |
Omnia Ameen [21] | Rat | Male | 350–400 | 18–20 months | 10/10 | Aging-dependent male osteoporosis | Receiving resveratrol; 20 mg/kg/day for 6 weeks | Balp |
Wei Wan [34] | Rat | Female | 250 ± 10 | 10–12 weeks | 10/10(low-dose)/10(middle)/10(high) | Ovariectomy | Res dissolved in 5 ml of normal saline and administered at the dosage of 10, 20, and 40 mg/kg/d to rats intragastrically for 8 weeks | Bmd |
Liwei Wei [36] | Rat | Female | NA | 6Â months | 8/8 | Ovariectomy | Two weeks after ovariectomy, rats in OVX and Res groups were received, respectively, Res solution at 10Â mg/kg body weight by daily intraperitoneal injection or saline for 12Â weeks | Bmd,BV/TV, Tb.Th,Tb.N, Tb.Sp, balp, pg, TRACP-5b, CTX-1 |
Alka Khera [28] | Rat | Female | NA | 3 months | 6/6 | Ovariectomy | The diet was mixed with resveratrol (625 µg/Kg body weight/day) and administered orally to experimental animals as diet pellets for 4 weeks | Bmd |
Zamai et al. [38] | Rat | Female | NA | 4Â months | 10/10 | Ovariectomy | The administration of Res (10Â mg/Kg) and placebo was performed via gavage during all experiment period after ovariectomy surgery; 22Â weeks | Tb.N,Tb.Sp, BV/TV |
Qian Lin [29] | Rat | Female | 254.91 ± 18.01 | 3 months | 8/8 | Ovariectomy | OVX rats with Res 5 mg, 15 mg, 45 mg × kgbw-1 × day-1, respectively, for 13 weeks | Bmd |
Yan-Ling Feng [26] | Rat | Female | 220 ± 19.27 | 3 months | 10/10 | Ovariectomy | RES solution (40 mg/kg body weight, once daily; 10 weeks | Bmd,BV/TV, Tb.Th,Tb.N, Tb.Sp |
Elseweidy et al. [24] | Rat | Female | 200–220 | 3 months | 6/6 | Ovariectomy | OVX rats that received 80 mg/kg/day of Res orally for 8 weeks (Res) | Bmd, CTX-1, alp |
Yixuan Jiang [27] | Mice | Female | NA | 8Â weeks | 4/4 | Ovariectomy | RES (40Â mg/kg body weight) was performed intraperitoneally once every day for 8Â weeks | BV/TV,Tb.N, Tb.Sp, CTX-1 |
Liu et al. [17] | Rat | Female | 220–250 | NA | 11/11 | Ovariectomy | RES group treated with 0.7 mg/kg of body weight of resveratrol. Tested materials were given by gavage for 12 weeks after ovariectomy | Bmd |
Haifeng Zhao [19] | Rat | Female | 200–220 | 3–4 months | 10/10(low-dose)/10(middle)/10(high) | Ovariectomy | Res(20, 40,,80 mg/kg/day) was orally administered, respectively, through a custom-made stomach tube for 12 weeks | Bmd,Tb.Th, Tb.N, Tb.Sp, alp |
Lee et al. [15] | Rat | Male | NA | 6Â months | 7/7 | Ageing rats | 20Â mg/kg/day; 3Â months | BV/TV,OC,alp, CTX-1 |
Tresguerres et al. [33] | Rat | Male | NA | 22Â months | 10/10 | Ageing rats | Treated with Res at dosages of 10Â mg/kg per day; 10Â weeks | BV/TV,Tb.Th, Tb.N,Tb.Sp, CTX-1, OC |
Sehmisch et al. [32] | Rat | Female | 220–260 | 3 months | 11/11(low-dose)/11(high) | Ovariectomy | The rats received daily doses of 5 mg/kg bw for RES low and 50 mg/kg bw for RES high; 3 months | Bmd |
Ye Zhang [39] | Rat | Female | NA | NA | 8/8(low-dose)/8(middle)/8(high) | Ovariectomy | Given orally with RES (50, 100, and 200Â mg/day); 12Â weeks | Bmd,balp, opg, TRAP-5b, CTX-1, alp,BV/TV, Tb.Th, Tb.N, Tb.Sp |
Yujin Zhang [40] | Rat | Female | 220 ± 18 | 3 months | 8/8(low-dose)/8(middle)/8(high) | Ovariectomy | RES-L, RES-M and RES-H treatment group were, respectively, given RES (dimethyl sulfoxide, DWSO), the concentration of DWSO in the solution was 0.5% of 5 mg/(kg.d), 15 mg/(kg.d) and 45 mg/(kg.d) by gavage; 12 weeks | Bmd,oc,alp, CTX-1 |
Wang(35) | Rat | Female | 300 | 12Â weeks | 8/8(low-dose)/8(high) | Ovariectomy | Resveratrol(5Â mg/kg/day)/ (45Â mg/kg/day) was administered orally, respectively, to rats for 10Â weeks | Bmd,BV/TV, Tb.Th,Tb.N, Tb.Sp, opg |
Yuquan Shi[37] | Mice | Female | NA | 8Â weeks | 8/8 | Ovariectomy | The mice received treatment with Res (7Â mg/kg) on the second day after OVX surgery; 6Â weeks | BV/TV,Tb.Th, Tb.N,Tb.Sp, balp, TRAP-5b |
Sakr et al. [31] | Rat | Male | 300 ± 25 | 14 weeks | 8/8 | Orchiectomy | Res time-release pellets (50 mg, Cat. No. NX-999) were implanted subcutaneously (one pellet/animal) to release the whole concentration of Res over 90 days | Bmd,opg,TRAP-5b, OC, alp |
Osturk et al. [30] | Rat | Female | 200–250 | 3 months | 12/12(low-dose)/12(high) | Ovariectomy | Res was administered by oral gavage (40 and 80 mg/kg/day) for ten weeks | Bmd, Alp, OC, BV/TV,Tb.Th, Tb.Sp |
Zuozhong Liu [41] | Mice | Female | NA | 8Â weeks | 6/6 | Ovariectomy | The mice received treatment with Res (7Â mg/kg) on the second day after OVX surgery; 6Â weeks | BV/TV,Tb.Th, Tb.N, Tb.Sp |
Basem [22] | Rat | Female | 365 ± 10 | 12–14 weeks | 10/10 | Ovariectomy | 45 µg/kg/day, orally by gavage; 16 weeks | Bmd,opg,TRAP-5b, OC, alp |